Immediate‐release methylphenidate vs lithium
Harms: adverse events (poorly assessed and reported) · adults with ADHD (available evidence for participants aged between 25 to 53 years old)
The review found no eligible studies for this question.
1 finding from 1 review
- Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults 2021 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found